Clinical trial

Individualized Triple-therapy Using Boceprevir in HIV-positive Patients With Hepatitis C

NCT01925183

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-08-01

PhasePHASE4

Study timeline

Study start (unknown)2013-08-01Date precision: month

Registry last updated2017-03-16

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hepatitis C, Chronicunresolved

HIVunresolved

Interventions

Pegylated interferon alpha-2aDRUG

RibavirinDRUG · verified · RxNorm: ribavirin

BoceprevirDRUG

Sponsors & collaborators

Markus Peck-Radosavljeviclead sponsor

Medical University of Viennacollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01925183 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.